Turn the Tide Act

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9759 Introduced in House (IH)]

<DOC>

119th CONGRESS
  2d Session
                                H. R. 9759

 To provide funding for programs and activities under the SUPPORT for
                     Patients and Communities Act.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 16, 2026

 Mr. Pappas (for himself and Ms. Goodlander) introduced the following
 bill; which was referred to the Committee on Energy and Commerce, and
    in addition to the Committees on Ways and Means, the Judiciary,
Oversight and Government Reform, Education and Workforce, and Financial
Services, for a period to be subsequently determined by the Speaker, in
   each case for consideration of such provisions as fall within the
                jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 To provide funding for programs and activities under the SUPPORT for
                     Patients and Communities Act.

    Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Turn the Tide Act''.

SEC. 2. CONTROLLED SUBSTANCE PROVISIONS OF THE SUPPORT FOR PATIENTS AND
              COMMUNITIES ACT.

    (a) Grants To Enhance Access to Substance Use Disorder Treatment.--
Section 3203 of the SUPPORT for Patients and Communities Act (Public
Law 115-271) is amended--
            (1) by striking ``The Secretary'' and inserting the
        following:
    ``(a) In General.--The Secretary''; and
            (2) by adding at the end the following:
    ``(b) Appropriations.--For grants under subsection (a), there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $4,000,000 for each
of fiscal years 2027 through 2030.''.
    (b) Access to Increased Drug Disposal.--Section 3260 of the SUPPORT
for Patients and Communities Act (Public Law 115-271) is amended to
read as follows:

``SEC. 3260. APPROPRIATIONS.

    ``To carry out this chapter, there is authorized to be
appropriated, and there is appropriated, out of any monies in the
Treasury not otherwise appropriated, $10,000,000 for each of fiscal
years 2027 through 2030.''.

SEC. 3. PUBLIC HEALTH PROVISIONS OF THE SUPPORT FOR PATIENTS AND
              COMMUNITIES ACT.

    (a) First Responder Training.--Section 546(h) of the Public Health
Service Act (42 U.S.C. 290ee-1(h)) is amended to read as follows:
    ``(h) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $77,000,000 for each
of fiscal years 2027 through 2030.''.
    (b) Public Health Laboratories Pilot Program.--Section 7011(d) of
the SUPPORT for Patients and Communities Act (Public Law 115-271) is
amended to read as follows:
    ``(d) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $15,000,000 for each
of fiscal years 2027 through 2030.''.
    (c) Model Training Programs for Substance Use Disorder Patient
Records.--Section 7053 of the SUPPORT for Patients and Communities Act
(Public Law 115-271) is amended by adding at the end the following:
    ``(e) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated--
            ``(1) $4,000,000 for fiscal year 2027;
            ``(2) $2,000,000 for fiscal year 2028; and
            ``(3) $1,000,000 for each of fiscal years 2029 and 2030.''.
    (d) Residential Treatment Programs for Pregnant and Postpartum
Women.--Section 508(s) of the Public Health Service Act (42 U.S.C.
290bb-1(s)) is amended by striking the first sentence and inserting the
following: ``To carry out this section, there is authorized to be
appropriated, and there is appropriated, out of any monies in the
Treasury not otherwise appropriated, $50,000,000 for each of fiscal
years 2027 through 2030.''.
    (e) Mental and Behavioral Health Education and Training Grants.--
Section 756(f) of the Public Health Service Act (42 U.S.C. 294e-1(f))
is amended to read as follows:
    ``(f) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $75,000,000 for each
of fiscal years 2027 through 2030.''.
    (f) Coordination and Continuation of Care for Drug Overdose
Patients.--Section 7081(f) of the SUPPORT for Patients and Communities
Act (42 U.S.C. 290dd-4) is amended to read as follows:
    ``(f) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $10,000,000 for each
of fiscal years 2027 through 2030.''.
    (g) Emergency Department Alternatives to Opioids Demonstration
Program.--Section 7091(g) of the SUPPORT for Patients and Communities
Act (Public Law 115-271) is amended to read as follows:
    ``(g) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $10,000,000 for each
of fiscal years 2027 through 2030.''.
    (h) Regional Centers of Excellence in Substance Use Disorder
Education.--Section 551(f) of the Public Health Service Act (42 U.S.C.
290ee-6(f)) is amended to read as follows:
    ``(f) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $4,000,000 for each
of fiscal years 2027 through 2030.''.
    (i) Youth Prevention and Recovery.--Section 7102(c)(9) of the
SUPPORT for Patients and Communities Act (Public Law 115-271) is
amended to read as follows:
            ``(9) Appropriations.--To carry out this subsection, there
        is authorized to be appropriated, and there is appropriated,
        out of any monies in the Treasury not otherwise appropriated,
        $20,000,000 for each of fiscal years 2027 through 2030.''.
    (j) Comprehensive Opioid Recovery Centers.--Section 552(j) of the
Public Health Service Act (42 U.S.C. 290ee-7(j)) is amended to read as
follows:
    ``(j) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $10,000,000 for each
of fiscal years 2027 through 2030.''.
    (k) CDC Surveillance and Data Collection.--Section 7131(e) of the
SUPPORT for Patients and Communities Act (42 U.S.C. 242t(e)) is amended
to read as follows:
    ``(e) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $2,000,000 for each
of fiscal years 2027 through 2030.''.
    (l) National Child Traumatic Stress Initiative.--Section 582(j) of
the Public Health Service Act (42 U.S.C. 290hh-1(j)) is amended to read
as follows:
    ``(j) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $112,000,000 for
each of fiscal years 2027 through 2030.''.
    (m) Trauma Support Services and Mental Health Care.--Section
7134(l) of the SUPPORT for Patients and Communities Act (42 U.S.C.
280h-7(l)) is amended to read as follows:
    ``(l) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $50,000,000 for each
of fiscal years 2027 through 2030.''.
    (n) Surveillance and Education Regarding Infections Associated With
Illicit Drug Use and Other Risk Factors.--Section 317N(d) of the Public
Health Service Act (42 U.S.C. 247b-15(d)) is amended to read as
follows:
    ``(d) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $40,000,000 for each
of fiscal years 2027 through 2030.''.
    (o) Building Communities of Recovery.--Section 547(f) of the Public
Health Service Act (42 U.S.C. 290ee-2(f)) is amended to read as
follows:
    ``(f) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $28,000,000 for each
of fiscal years 2027 through 2030.''.
    (p) Peer Support Technical Assistance Center.--Section 547A(f) of
the Public Health Service Act (42 U.S.C. 290ee-2a(f)) is amended to
read as follows:
    ``(f) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $4,000,000 for each
of fiscal years 2027 through 2030.''.
    (q) Preventing Overdoses of Controlled Substances.--Section 392A(e)
of the Public Health Service Act (42 U.S.C. 280b-1(e)) is amended to
read as follows:
    ``(e) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $516,000,000 for
each of fiscal years 2027 through 2030.''.
    (r) Career Act.--Section 7183(k) of the SUPPORT for Patients and
Communities Act (42 U.S.C. 290ee-8(k)) is amended to read as follows:
    ``(k) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $19,000,000 for each
of fiscal years 2027 through 2030.''.

SEC. 4. HOUSING AND DEPARTMENT OF JUSTICE PROVISIONS OF THE SUPPORT FOR
              PATIENTS AND COMMUNITIES ACT.

    (a) Reauthorization and Improvement of Recovery Housing Program.--
Section 8071 of the SUPPORT for Patients and Communities Act (42 U.S.C.
5301 note; Public Law 115-271) is amended--
            (1) in subsection (a), by striking ``such sums as may be
        necessary for each of fiscal years 2019 through 2030'' and
        inserting ``$60,000,000 for each of fiscal years 2027 through
        2032'';
            (2) in subsection (b)--
                    (A) in paragraph (1), by striking ``date of
                enactment of the SUPPORT for Patients and Communities
                Reauthorization Act of 2025'' and inserting ``date of
                enactment of the Turn the Tide Act''; and
                    (B) by striking paragraph (2) and inserting the
                following:
            ``(2) Priority.--
                    ``(A) In general.--The funding formula required
                under paragraph (1) shall ensure that priority for
                amounts appropriated or otherwise made available under
                this section is given to States with the greatest need,
                as such need is determined by the Secretary based on
                the following factors, and weighting such factors as
                described in subparagraph (B):
                            ``(i) The highest average rates of
                        unemployment based on data provided by the
                        Bureau of Labor Statistics for calendar years
                        2023 through 2027.
                            ``(ii) The lowest average labor force
                        participation rates based on data provided by
                        the Bureau of Labor Statistics for calendar
                        years 2023 through 2027.
                            ``(iii) The highest average age-adjusted
                        rates of drug overdose deaths based on data
                        from the Centers for Disease Control and
                        Prevention for the 3 most recent calendar
                        years.
                    ``(B) Weighting.--The factors described in
                subparagraph (A) shall be weighted as follows:
                            ``(i) The rate described in subparagraph
                        (A)(i) shall be weighted at 15 percent.
                            ``(ii) The rate described in subparagraph
                        (A)(ii) shall be weighted at 15 percent.
                            ``(iii) The rate described in subparagraph
                        (A)(iii) shall be weighted at 70 percent.'';
                        and
            (3) in subsection (c)(1), by striking ``at least 30 percent
        of such funds within one year'' and inserting ``at least 50
        percent of such funds within 2 years''.
    (b) Building Capacity for Family-Focused Residential Treatment.--
Section 8083(c) of the SUPPORT for Patients and Communities Act (Public
Law 115-271) is amended to read as follows:
    ``(c) Appropriations.--To carry out this section, there is
authorized to be appropriated, and there is appropriated, out of any
monies in the Treasury not otherwise appropriated, $20,000,000 for
fiscal year 2027, which shall remain available through fiscal year
2030.''.
    (c) Comprehensive Opioid Abuse Grant Program.--Section 1001(a)(27)
of title I of the Omnibus Crime Control and Safe Streets Act of 1968
(34 U.S.C. 10261(a)(27)) is amended to read as follows:
    ``(27) To carry out part LL, there is authorized to be
appropriated, and there is appropriated, out of any monies in the
Treasury not otherwise appropriated, $500,000,000 for each of fiscal
years 2027 through 2030.''.
    (d) Office of National Drug Control Policy.--Section 714 of the
Office of National Drug Control Policy Reauthorization Act of 1998 (21
U.S.C. 1711) is amended to read as follows:

``SEC. 714. AUTHORIZATION OF APPROPRIATIONS; APPROPRIATIONS.

    ``To carry out this title, except activities otherwise specified,
there is authorized to be appropriated, and there is appropriated, out
of any monies in the Treasury not otherwise appropriated, $50,000,000
for each of fiscal years 2027 through 2030, to remain available until
expended.''.
    (e) Drug-Free Communities Program.--Section 1024 of the Anti-Drug
Abuse Act of 1988 (21 U.S.C. 1524) is amended--
            (1) in the heading, by inserting ``; appropriations'' after
        ``authorization of appropriations''; and
            (2) by striking subsection (a) and inserting the following:
    ``(a) In General.--To carry out this chapter, there is authorized
to be appropriated to the Office of National Drug Control Policy, and
there is appropriated, out of any monies in the Treasury not otherwise
appropriated, $175,000,000 for each of fiscal years 2027 through
2030.''.
    (f) High-Intensity Drug Trafficking Area Program.--Section 707(p)
of the Office of National Drug Control Policy Reauthorization Act of
1998 (21 U.S.C. 1706(p)) is amended--
            (1) by redesignating paragraphs (1) through (6) as
        subparagraphs (A) through (F), respectively, and adjusting the
        margins accordingly;
            (2) by striking ``There is authorized'' and inserting the
        following:
            ``(1) In general.--There is authorized'';
            (3) in paragraph (1), as so designated--
                    (A) in subparagraph (E), as so redesignated, by
                striking ``each of''; and
                    (B) in subparagraph (F), as so redesignated, by
                striking ``2018 through 2023'' and inserting ``2027
                through 2030''; and
            (4) by adding at the end the following:
            ``(2) Appropriations.--To carry out this section, there is
        authorized to be appropriated to the Office of National Drug
        Control Policy, and there is appropriated, out of any monies in
        the Treasury not otherwise appropriated, $350,000,000 for each
        of fiscal years 2027 through 2030.''.
    (g) Drug Court Program.--Section 1001(a)(25)(A) of title I of the
Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C.
10261(a)(25)(A)) is amended to read as follows:
    ``(25)(A) Except as provided in subparagraph (C), to carry out part
EE, there is authorized to be appropriated, and there is appropriated,
out of any monies in the Treasury not otherwise appropriated,
$125,000,000 for each of fiscal years 2027 through 2030.''.
    (h) Drug Court Training and Technical Assistance.--Section
705(e)(2) of Office of National Drug Control Policy Reauthorization Act
of 1998 (21 U.S.C. 1704(e)(2)) is amended to read as follows:
            ``(2) Authorization of appropriations; appropriations.--To
        carry out this subsection, there is authorized to be
        appropriated, and there is appropriated, out of any monies in
        the Treasury not otherwise appropriated, $5,000,000 for each of
        fiscal years 2027 through 2030.''.
    (i) Administration of the Office of National Drug Control Policy.--
Section 704(i)(2) of the Office of National Drug Control Policy
Reauthorization Act of 1998 (21 U.S.C. 1703(i)(2)) is amended to read
as follows:
            ``(2) Authorization of appropriations; appropriations.--To
        carry out this subsection, there is authorized to be
        appropriated, and there is appropriated, out of any monies in
        the Treasury not otherwise appropriated, $1,750,000 for each of
        fiscal years 2027 through 2030.''.
    (j) Emerging Threats Committee, Plan, and Media Campaign.--Section
709(g) of the Office of National Drug Control Policy Reauthorization
Act of 1998 (21 U.S.C. 1708(g)) is amended to read as follows:
    ``(g) Authorization of Appropriations; Appropriations.--To carry
out this section, there is authorized to be appropriated to the Office,
and there is appropriated, out of any monies in the Treasury not
otherwise appropriated, $35,000,000 for each of fiscal years 2027
through 2030.''.

SEC. 5. BOLSTERING COMMITMENTS TO STATE GRANTS FOR SUBSTANCE USE
              DISORDER TREATMENT AND PREVENTION.

    (a) State Opioid Response Grants.--
            (1) In general.--To carry out activities under section 1003
        of the 21st Century Cures Act (42 U.S.C. 290ee-3 note) relating
        to opioids by the State agency responsible for administering
        the substance abuse prevention and treatment block grant under
        subpart II of part B of title XIX of the Public Health Service
        Act (42 U.S.C. 300x-21 et seq.), there is authorized to be
        appropriated, and there is appropriated, $5,500,000,000 for
        each of fiscal years 2027 through 2031.
            (2) Flexibility in use of funds.--Section 1003(b) of the
        21st Century Cures Act (42 U.S.C. 290ee-3a(b)) is amended by
        adding at the end the following:
            ``(5) Flexibility.--States and Indian Tribes may use
        amounts provided under grants under this subsection to support
        substance use disorder treatment care and related services
        regardless of whether the patient involved has a primary
        diagnosis of opioid use disorder, so long as the individual has
        a substance use disorder diagnosis.
            ``(6) Rule of construction.--Nothing in this subsection
        shall be construed to prohibit States from using grant funds
        under this subsection to allocate amounts to local governments
        to establish subgrantee awards in such localities.''.
            (3) Substance abuse prevention and treatment block
        grants.--Section 1935(a) of the Public Health Service Act (42
        U.S.C. 300x-35(a)) is amended to read as follows:
    ``(a) Appropriations.--To carry out this subpart, subpart III, and
section 505(d), there is authorized to be appropriated, and there is
appropriated, out of any monies in the Treasury not otherwise
appropriated, $3,000,000,000 for each of fiscal years 2027 through
2031, and $2,500,000,000 for each of fiscal years 2032 through 2036.''.
    (b) Requirements.--For the purposes of carrying out activities with
amounts appropriated under this section (and the amendment made by this
section), the Secretary of Health and Human Services shall ensure that
the following requirements are complied with:
            (1) Of the amount appropriated for each fiscal year under
        subsection (a) (and the amendment made by such subsection),
        $50,000,000 shall be made available to Indian Tribes or Tribal
        organizations.
            (2) Of such remaining amounts for each such fiscal year, 15
        percent shall be made available to the States with the highest
        mortality rate related to opioid use disorders. For purposes of
        allocating such funds, the Secretary shall develop a formula
        that avoids a significant cliff between States with similar
        mortality rates to prevent unusually large changes in certain
        States when compared to prior year allocations, including
        consideration of new formula methodologies to avoid such
        funding cliffs.
            (3) Of the amount made available for each fiscal year under
        subsection (a)(1) for State Opioid Response Grants, not more
        than 2 percent of such amount shall be available for Federal
        administrative expenses, training, technical assistance, and
        evaluation.
            (4) Of the amounts not reserved under paragraphs (1)
        through (3), the Secretary shall make allocations to States,
        territories, and the District of Columbia according to a
        formula using national survey results that the Secretary
        determines are the most objective and reliable measure of drug
        use and drug-related deaths.
            (5) The formula methodology under paragraph (4) shall be
        submitted to the Committees on Appropriations of the House of
        Representatives and the Committee on Appropriations of the
        Senate not less than 15 days prior to publishing a Funding
        Opportunity Announcement.
            (6) The prevention and treatment activities funded through
        grants under this section may include education, treatment
        (including the provision of medication), behavioral health
        services for individuals in treatment programs, referral to
        treatment services, recovery support, and medical screening
        associated with such treatment.
            (7) Each State, including the District of Columbia, shall
        receive not less than $4,000,000 under grants under this
        section.
            (8) In addition to amounts appropriated under this section
        (and the amendment made by this section), the following amounts
        shall be available under section 241 of the Public Health
        Service Act (42 U.S.C. 238j):
                    (A) In addition to amounts appropriated under
                section 1935(a) of the Public Health Service Act (42
                U.S.C. 300x-35(a)), an additional $79,200,000 to carry
                out the provisions referred to in such section 1935(a)
                (relating to technical assistance, national data, data
                collection and evaluation activities) and the total
                available under this Act for activities under section
                1935(b) of such Act shall not exceed 5 percent of the
                amounts appropriated for subpart II of part B of title
                XIX of such Act.
                    (B) $2,000,000 to evaluate substance abuse
                treatment programs.
            (9) None of the funds provided for under section 1921 of
        the Public Health Service Act (42 U.S.C. 300x-21) or for State
        Opioid Response Grants under section 1003 of the 21st Century
        Cures Act (42 U.S.C. 290ee-3a) shall be subject to section 241
        of the Public Health Service Act (42 U.S.C. 238j).

SEC. 6. ELIMINATING INSURANCE BARRIERS TO MEDICATION-ASSISTED
              TREATMENT.

    (a) Prohibition.--Section 1903(i) of the Social Security Act (42
U.S.C. 1396b(i)) is amended--
            (1) in paragraph (26), by striking ``; or'' and inserting a
        semicolon;
            (2) in paragraph (27), by striking the period at the end
        and inserting ``; or''; and
            (3) by inserting after paragraph (27) the following new
        paragraph:
            ``(28) with respect to any amount expended for medical
        assistance for medication-assisted treatment (as defined in
        section 1905(ee)) if the State imposes any utilization control
        policies or procedures (as defined by the Secretary), including
        any prior authorization requirements, with respect to the
        provision of such assistance.''.
    (b) Conforming Amendment.--Section 1905(a)(29) of the Social
Security Act (42 U.S.C. 1396d(a)(29)) is amended by inserting ``and
section 1903(i)(28)'' after ``subsection (ee)''.
    (c) Effective Date.--The amendments made by this subsection take
effect on October 1, 2026.

SEC. 7. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE REVERSAL
              MEDICATIONS.

    (a) Limitations on Cost-Sharing.--
            (1) Public health service act.--Part D of title XXVII of
        the Public Health Service Act (42 U.S.C. 300gg-111 et seq.) is
        amended by adding at the end the following:

``SEC. 2799A-12. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE
              REVERSAL AGENTS.

    ``(a) In General.--A group health plan or a health insurance issuer
offering group or individual health insurance coverage shall provide
coverage for, and shall not impose any cost-sharing requirement under
the plan or coverage with respect to at least one formulation of an
opioid overdose reversal agent.
    ``(b) Utilization Control Policies; Medical Management.--A group
health plan or health insurance issuer offering group or individual
health insurance coverage shall not impose any utilization control
policies or procedures (as defined by the Secretary), including prior
authorization requirements, with respect to opioid overdose reversal
agents covered under the plan or coverage. Such a plan or issuer may
apply medical management practices in providing the benefits described
in subsection (a).
    ``(c) Definition.--In this section, the term `opioid overdose
reversal agent' means a drug or biological product approved by the Food
and Drug Administration for one of the following uses (or a similar
use):
            ``(1) Complete or partial reversal of opioid depression,
        including respiratory depression, induced by opioids.
            ``(2) Emergency treatment of a known or suspected opioid
        overdose, as manifested by respiratory or central nervous
        system depression.''.
            (2) Employee retirement income security act of 1974.--
                    (A) In general.--Subpart B of part 7 of subtitle B
                of title I of the Employee Retirement Income Security
                Act of 1974 (29 U.S.C. 1185 et seq.) is amend by adding
                at the end the following:

``SEC. 727. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE REVERSAL
              AGENTS.

    ``(a) In General.--A group health plan or a health insurance issuer
offering group health insurance coverage shall provide coverage for,
and shall not impose any cost-sharing requirement under the plan or
coverage with respect to at least one formulation of an opioid overdose
reversal agent.
    ``(b) Utilization Control Policies; Medical Management.--A group
health plan or health insurance issuer offering group health insurance
coverage shall not impose any utilization control policies or
procedures (as defined by the Secretary), including prior authorization
requirements, with respect to opioid overdose reversal agents covered
under the plan or coverage. Such a plan or issuer may apply medical
management practices in providing the benefits described in subsection
(a).
    ``(c) Definition.--In this section, the term `opioid overdose
reversal agent' means a drug or biological product approved by the Food
and Drug Administration for one of the following uses (or a similar
use):
            ``(1) Complete or partial reversal of opioid depression,
        including respiratory depression, induced by opioids.
            ``(2) Emergency treatment of a known or suspected opioid
        overdose, as manifested by respiratory or central nervous
        system depression.''.
                    (B) Clerical amendment.--The table of contents in
                section 1 of the Employee Retirement Income Security
                Act of 1974 (29 U.S.C. 1001 et seq.) is amended by
                inserting after the item relating to section 726 the
                following new item:

``Sec. 727. Limitations on cost-sharing for opioid overdose reversal
                            agents.''.
            (3) Internal revenue code of 1986.--
                    (A) In general.--Subchapter B of chapter 100 of the
                Internal Revenue Code of 1986 is amended by adding at
                the end the following:

``SEC. 9827. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE REVERSAL
              AGENTS.

    ``(a) In General.--A group health plan shall provide coverage for,
and shall not impose any cost-sharing requirement under the plan with
respect to at least one formulation of an opioid overdose reversal
agent.
    ``(b) Utilization Control Policies; Medical Management.--A group
health plan shall not impose any utilization control policies or
procedures (as defined by the Secretary), including prior authorization
requirements, with respect to opioid overdose reversal agents covered
under the plan. Such a plan may apply medical management practices in
providing the benefits described in subsection (a).
    ``(c) Definition.--In this section, the term `opioid overdose
reversal agent' means a drug or biological product approved by the Food
and Drug Administration for one of the following uses (or a similar
use):
            ``(1) Complete or partial reversal of opioid depression,
        including respiratory depression, induced by opioids.
            ``(2) Emergency treatment of a known or suspected opioid
        overdose, as manifested by respiratory or central nervous
        system depression.''.
                    (B) Clerical amendment.--The table of sections for
                subchapter B of chapter 100 of the Internal Revenue
                Code of 1986 is amended by adding at the end the
                following new item:

``Sec. 9827. Limitations on cost-sharing for opioid overdose reversal
                            agents.''.
            (4) Effective date.--The amendments made by this subsection
        shall apply to plan years beginning on or after January 1,
        2027.
    (b) Safe Harbor for Absence of Deductible for Opioid Overdose
Reversal Agents.--
            (1) In general.--Paragraph (2) of section 223(c) of the
        Internal Revenue Code of 1986 is amended by adding at the end
        the following new subparagraph:
                    ``(I) Safe harbor for absence of deductible for
                opioid overdose reversal agents.--A plan shall not fail
                to be treated as a high deductible health plan by
                reason of failing to have a deductible for opioid
                overdose reversal agents (as defined in section
                9827(c)).''.
            (2) Effective date.--The amendment made by this section
        shall apply to plan years beginning on or after January 1,
        2027.
    (c) Limitations on Cost-Sharing Under Medicare Part D.--
            (1) In general.--Section 1860D-2 of the Social Security Act
        (42 U.S.C. 1395w-102) is amended--
                    (A) in subsection (b)--
                            (i) in paragraph (1)(A), in the matter
                        preceding clause (i), by striking ``and (9)''
                        and inserting ``, (9), and (10)'';
                            (ii) in paragraph (2)(A), in the matter
                        preceding clause (i), by striking ``and (9)''
                        and inserting ``, (9), and (10)''; and
                            (iii) by adding at the end the following
                        new paragraph:
            ``(10) Limitations on cost-sharing for opioid overdose
        reversal agents.--
                    ``(A) In general.--For plan year 2027 and each
                subsequent plan year, each prescription drug plan and
                MA-PD plan shall not impose any cost-sharing
                requirement under the plan with respect to at least one
                brand or generic version of an opioid overdose reversal
                agent (as defined in section 2799A-11 of the Public
                Health Service Act). The requirement under the
                preceding sentence shall also apply to cost-sharing
                applicable to subsidy eligible individuals under
                section 1814D-14.
                    ``(B) Cost-sharing.--For purposes of subparagraph
                (A), the elimination of cost-sharing shall include the
                following:
                            ``(i) No application of deductible.--The
                        waiver of the deductible under paragraph (1).
                            ``(ii) No application of coinsurance.--The
                        waiver of coinsurance under paragraph (2).'';
                        and
                    (B) in subsection (c), by adding at the end the
                following new paragraph:
            ``(7) Treatment of cost-sharing for opioid overdose
        reversal agents.--The coverage is provided in accordance with
        subsection (b)(10).''.
            (2) Conforming amendments to cost-sharing for low-income
        individuals.--Section 1860D-14(a)(1) of the Social Security Act
        (42 U.S.C. 1395w-114(a)(1)) is amended, in the matter preceding
        subparagraph (A), by striking ``In the case'' and inserting
        ``Subject to section 1860D-2(b)(10), in the case''.

SEC. 8. TARGETING HEALTH WORKFORCE LOAN REPAYMENT ASSISTANCE TO
              HARDEST-HIT STATES.

    (a) Loan Repayment Program for Substance Use Disorder Treatment
Workforce.--Section 781 of the Public Health Service Act (42 U.S.C.
295h) is amended--
            (1) in subsection (b), by adding at the end the following:
            ``(3) Tax liability.--The amount of a payment made under
        this section on behalf of an individual shall not be considered
        income for any purpose under the Internal Revenue Code of
        1986.''; and
            (2) in subsection (j), by striking ``$40,000,000 for each
        of fiscal years 2026 through 2030'' and inserting ``$65,000,000
        for each of fiscal years 2027 through 2031''.
    (b) Training Demonstration Program.--Section 760(g) of the Public
Health Service Act (42 U.S.C. 294k(g)) is amended to read as follows:
    ``(g) Appropriations.--
            ``(1) In general.--To carry out this section (other than
        paragraph (2)), there is authorized to be appropriated, and
        there is appropriated, out of any monies in the Treasury not
        otherwise appropriated, $10,000,000 for each of fiscal years
        2027 through 2030.
            ``(2) States with highest drug overdose death rates.--
                    ``(A) In general.--To carry out the program under
                this section with respect to grantees located in States
                described in subparagraph (B), there is authorized to
                be appropriated, and there is appropriated, out of any
                monies in the Treasury not otherwise appropriated,
                $20,000,000 for each of fiscal years 2027 through 2030.
                    ``(B) States described.--A State described in this
                subparagraph is a State that is among the top 10 States
                in terms of highest per capita drug poisoning deaths in
                each of calendar years 2023, 2024, and 2025, based on
                the most recent data available from the Centers for
                Disease Control and Prevention.
                    ``(C) Application of section.--Except as provided
                in this paragraph, the requirements of this section
                otherwise applicable to grantees under this section
                shall apply to grantees receiving assistance under this
                paragraph.''.

SEC. 9. MEDICAID PAYMENTS FOR BEHAVIORAL HEALTH AND MENTAL HEALTH
              PROVIDERS.

    (a) In General.--
            (1) Fee-for-service.--Section 1902 of the Social Security
        Act (42 U.S.C. 1396a) is amended--
                    (A) in subsection (a)(13)--
                            (i) by striking ``and'' at the end of
                        subparagraph (B);
                            (ii) by adding ``and'' at the end of
                        subparagraph (C); and
                            (iii) by adding at the end the following
                        new subparagraph:
                    ``(D) payment for mental health and behavioral
                health services (as defined in subsection (zz)(1))
                furnished on or after October 1, 2026, and before
                October 1, 2030, by a physician or applicable
                professional (as defined in subsection (zz)(2)) at a
                rate that is not less than 100 percent of the payment
                rate that applies to such services and physician or
                applicable professional under part B of title XVIII
                (or, if greater, the payment rate that would be
                applicable under such part if the conversion factor
                under section 1848(d) for the year involved were the
                conversion factor under such section for 2026, and, if
                such services are not covered under such part, the
                reasonable and customary rate the Secretary determines
                would apply to such services and physician or
                applicable professional);''; and
                    (B) by adding at the end the following new
                subsection:
    ``(zz) Mental Health and Behavioral Health Services.--For purposes
of subsection (a)(13)(D):
            ``(1) Mental health and behavioral health services.--
                    ``(A) In general.--The term `mental health and
                behavioral health services' means the following
                services, when provided to a patient with a diagnosis
                of substance use disorder (as defined in subparagraph
                (B)) as a part of the management or treatment of the
                patient's substance use disorder (as determined in
                accordance with regulations promulgated by the
                Secretary under subparagraph (C)):
                            ``(i) Evaluation and management services
                        that are procedure codes (for services covered
                        under title XVIII) for services in the category
                        designated Evaluation and Management in the
                        Healthcare Common Procedure Coding System
                        (established by the Secretary under section
                        1848(c)(5) as of December 31, 2020, and as
                        subsequently modified).
                            ``(ii) Counseling services, as defined by
                        the Secretary.
                            ``(iii) Payment codes established by the
                        Secretary for opioid use disorder treatment
                        services under section 1866F.
                            ``(iv) Any other services the Secretary
                        determines are necessary for the management or
                        treatment of a patient with a diagnosis of
                        substance use disorder.
                    ``(B) Patient with a diagnosis of substance use
                disorder.--For purposes of subparagraph (A), the term
                `patient with a diagnosis of substance use disorder'
                means an individual who has been diagnosed with 1 or
                more diagnosis codes within the code set entitled the
                `Mental health and behavioral disorders due to
                psychoactive substance use' under the 10th revision of
                the International Statistical Classification of
                Diseases and Related Health Problems.
                    ``(C) Regulations.--Not later than 90 days after
                the enactment of this subsection, the Secretary shall
                promulgate regulations regarding when services are
                sufficiently related to part of the management or
                treatment of a patient's substance use disorder.
            ``(2) Applicable professional.--The term `applicable
        professional' means--
                    ``(A) a clinical psychologist (as defined for
                purposes of section 1861(ii));
                    ``(B) a clinical social worker (as defined in
                section 1861(hh)(1));
                    ``(C) a medical professional approved to furnish
                medication-assisted treatment under section 303(g)(2)
                of the Controlled Substances Act; or
                    ``(D) a medical professional that is authorized
                under the State plan or under a waiver of such plan to
                furnish mental and behavioral health services (as
                defined in paragraph (1)).''.
            (2) Managed care.--Section 1932(f) of such Act (42 U.S.C.
        1396u-2(f)) is amended--
                    (A) in the subsection heading, by inserting ``and
                Mental Health and Behavioral Health Services'' after
                ``Care Services''; and
                    (B) by inserting before the period at the end the
                following: ``, and, in the case of mental health and
                behavioral health services described in section
                1902(a)(13)(D), consistent with the minimum payment
                rates specified in such section (regardless of the
                manner in which such payments are made, including in
                the form of capitation or partial capitation)''.
    (b) Increased FMAP for Additional Costs.--Section 1905 of the
Social Security Act (42 U.S.C. 1396d) is amended--
            (1) in subsection (b), by striking ``and (ii)'' and
        inserting ``(ii), and (ll)''; and
            (2) by adding at the end the following new subsection:
    ``(ll) Increased FMAP for Additional Expenditures for Mental Health
and Behavioral Health Services.--
            ``(1) In general.--Notwithstanding subsection (b), with
        respect to the portion of the amounts expended for medical
        assistance for services described in section 1902(a)(13)(D)
        furnished on or after October 1, 2026, and before October 1,
        2030, that is attributable to the amount by which the minimum
        payment rate required under such section (or, by application,
        section 1932(f)) exceeds the payment rate applicable to such
        services under the State plan or a waiver of such plan as of
        July 1, 2026, the Federal medical assistance percentage for a
        State shall be equal to 100 percent. The preceding sentence
        shall not be construed as prohibiting the payment of Federal
        financial participation based on the Federal medical assistance
        percentage for the portion of the amounts expended for medical
        assistance for such services that is attributable to the amount
        (if any) by which the payment rate applicable to such services
        under the State plan or waiver exceeds such minimum payment
        rate.
            ``(2) Disregard of enhanced payments for purposes of
        territorial limits.--The amount of any payment made for
        expenditures on medical assistance that is attributable to the
        application of the Federal medical assistance percentage
        described in paragraph (1) shall not be taken into account for
        purposes of applying payment limits under subsections (f) and
        (g) of section 1108.''.

SEC. 10. CMI DEMONSTRATION TO TEST THE PROVISION OF RECOVERY HOUSING
              FOR INDIVIDUALS WITH OPIOID USE DISORDER UNDER MEDICAID.

    Section 1115A of the Social Security Act (42 U.S.C. 1315a) is
amended--
            (1) in subsection (b)(2)(A), by adding at the end the
        following new sentence: ``The models selected under this
        subparagraph shall include the demonstration described in
        subsection (h) (which shall be implemented not later than 18
        months after the date of enactment of such subsection).''; and
            (2) by adding at the end the following new subsection:
    ``(h) Demonstration To Test the Provision of Recovery Housing for
Individuals With Opioid Use Disorder Under Medicaid.--
            ``(1) In general.--The CMI, in consultation with the
        Secretary of Housing and Urban Development and other agencies,
        as the Secretary determines appropriate, shall conduct a
        demonstration project (referred to in this subsection as the
        `demonstration') to test whether providing Medicaid managed
        care entities with an elevated global capitated budget for
        eligible Medicaid beneficiaries, paired with flexibilities to
        allow States to provide medical assistance for recovery housing
        for such beneficiaries, would result in reduced emergency
        department visits, hospitalizations, and program expenditures
        under per beneficiary, or improve quality of care for the such
        beneficiaries without increasing expenditures under the
        Medicaid program under title XIX.
            ``(2) Demonstration requirements.--
                    ``(A) In general.--Under the demonstration, each
                eligible State that is selected by the CMI to
                participate in the demonstration shall enter into an
                agreement with a Medicaid managed care entity under
                which the entity agrees to provide services (including
                recovery housing) to eligible Medicaid beneficiaries
                under a payment model that meets the requirements of
                subparagraph (B).
                    ``(B) Capitated payments.--
                            ``(i) In general.--The CMI shall establish
                        a capitated payments system for Medicaid
                        managed care entities under the demonstration
                        that is based on the demonstration budget
                        determined under clause (ii).
                            ``(ii) Demonstration budget.--
                                    ``(I) In general.--For purposes of
                                clause (i), the demonstration budget of
                                a Medicaid managed care entity for each
                                year of a demonstration period shall be
                                determined by the CMI based on the
                                number of eligible Medicaid
                                beneficiaries enrolled with the entity
                                and the average annual spending under
                                title XIX in the State involved on
                                individuals who are enrolled in the
                                State plan under such title (or a
                                waiver of such plan) and who--
                                            ``(aa) have a diagnosis of
                                        opioid use disorder;
                                            ``(bb) are in the top
                                        quartile of per beneficiary
                                        spending for such plan or
                                        waiver for the most recent
                                        year; and
                                            ``(cc) have attained age 21
                                        but have not attained age 65.
                                    ``(II) Risk adjustment.--The CMI
                                may adjust the demonstration budget
                                determined for a Medicaid managed care
                                entity and a year under this clause
                                using a risk adjustment model selected
                                by the CMI to account for differences
                                in age and clinical conditions of the
                                eligible Medicaid beneficiaries
                                enrolled with the entity compared to
                                the overall population upon which the
                                demonstration budget is based.
                    ``(C) Selection of eligible states.--Not later than
                1 year after the date of enactment of this subsection,
                the CMI shall select not less than 2 eligible States to
                participate in the demonstration.
            ``(3) Additional waiver authority.--In addition to the
        authority described in subsection (d)(1), the Secretary may
        waive such requirements of title XIX as necessary to carry out
        the demonstration.
            ``(4) Definitions.--In this subsection:
                    ``(A) Eligible medicaid beneficiary.--The term
                `eligible Medicaid beneficiary' means an individual
                who--
                            ``(i) is eligible for medical assistance
                        under a State plan under title XIX or a waiver
                        of such a plan;
                            ``(ii) has a diagnosis of opioid use
                        disorder;
                            ``(iii) does not have a permanent residence
                        (as certified by the individual);
                            ``(iv) is currently receiving medication-
                        assisted treatment or completed a course of
                        medication-assisted treatment during the 3-
                        month period preceding the individual's
                        participation in the demonstration; and
                            ``(v) has attained age 21 but has not
                        attained age 65.
                    ``(B) Eligible state.--
                            ``(i) In general.--The term `eligible
                        State' means a State that--
                                    ``(I) makes medical assistance
                                available to all individuals described
                                in section 1902(a)(10)(A)(i)(VIII); and
                                    ``(II) agrees to participate in the
                                demonstration.
                            ``(ii) Selection of eligible states.--In
                        selecting eligible States to participate in the
                        demonstration, the CMI shall give priority to
                        States that are--
                                    ``(I) among the top 10 States in
                                terms of highest per capita drug
                                poisoning deaths in each of calendar
                                years 2023, 2024, and 2025, based on
                                the most recent data available from the
                                Centers for Disease Control and
                                Prevention; and
                                    ``(II) among the 10 States with the
                                lowest physician reimbursement rates
                                for services furnished under title XIX
                                (as determined by the Secretary) in
                                each of calendar years 2023, 2024, and
                                2025.
                    ``(C) Managed care entity.--The term `managed care
                entity' means a medicaid managed care organization
                described in section 1932(a)(1)(B)(i).
                    ``(D) Recovery housing.--The term `recovery
                housing' means a shared living environment free from
                alcohol and illicit drug use and centered on peer
                support and connection to services that promote
                sustained recovery from substance use disorders.
                    ``(E) State.--The term `State' includes the 50
                States and the District of Columbia.''.

SEC. 11. EXTENSION OF MEDICAID DELIVERY SYSTEM REFORM AND INCENTIVE
              PAYMENT WAIVERS.

    (a) Extension of Waivers.--In the case of a Medicaid section 1115
waiver described in subsection (b), not later than 60 days after the
date of enactment of this Act, the Secretary of Health and Human
Services shall--
            (1) extend the termination date for the waiver to December
        31, 2028 (or such earlier date as the State conducting the
        waiver may elect);
            (2) apply the same annual dollar allotment for the period
        for which the waiver is extended under paragraph (1) as the
        annual dollar allotment that applied to the waiver period in
        effect on the date of enactment of this Act; and
            (3) allow any State with such a waiver to use funds
        provided during the period for which the waiver is extended
        under paragraph (1) to support the training of direct service
        workers that provide home and community-based services.
    (b) Medicaid Section 1115 Waiver Described.--The Medicaid section
1115 waiver described in this subsection is a waiver approved under
section 1115 of the Social Security Act (42 U.S.C. 1315) relating to
delivery system reform incentive payments that--
            (1) as of the date of enactment of this Act, is to
        terminate on or before December 31, 2026;
            (2) was in effect as of January 1, 2022; and
            (3) was approved for any State that is among the top 10
        States in terms of highest per capita drug poisoning deaths in
        each of calendar years 2023, 2024, and 2025, based on the most
        recent data available from the Centers for Disease Control and
        Prevention.

SEC. 12. EXPANDING DRUG-FREE COMMUNITIES SUPPORT GRANTS.

    Section 1032 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1532) is
amended--
            (1) in subsection (b)--
                    (A) in paragraph (3)--
                            (i) in subparagraph (A), by striking
                        ``subparagraph (F)'' and inserting
                        ``subparagraph (H)'';
                            (ii) by redesignating subparagraphs (D),
                        (E), and (F) as subparagraphs (F), (G), and
                        (H), respectively;
                            (iii) by inserting after subparagraph (C)
                        the following:
                    ``(D) Subsequent additional grants.--Subject to
                subparagraph (H), the Administrator may award a
                subsequent additional grant to a grant recipient under
                subparagraph (A), for each fiscal year during the 4-
                fiscal-year period following the fiscal year for which
                the initial additional grant under subparagraph (A) is
                awarded, in an amount not to exceed the amount of non-
                Federal funds, including in-kind contributions, raised
                by the grant recipient for the fiscal year for which
                the subsequent additional grant is awarded.
                    ``(E) Renewal grants.--Subject to subparagraph (H),
                the Administrator may award a renewal grant to a grant
                recipient under subparagraph (D), for the first fiscal
                year following the 4-fiscal-year period for which the
                subsequent additional grant under subparagraph (D) is
                awarded, in an amount not to exceed the amount of non-
                Federal funds, including in-kind contributions, raised
                by the grant recipient for the fiscal year for which
                the renewal grant is awarded.''; and
                            (iv) in subparagraph (F), as so
                        redesignated--
                                    (I) in the subparagraph heading, by
                                striking ``renewal'' and inserting
                                ``subsequent renewal''; and
                                    (II) in the matter preceding clause
                                (i)--
                                            (aa) by striking ``clause
                                        (iv)'' and inserting
                                        ``subparagraph (H)'';
                                            (bb) by striking ``renewal
                                        grant to a grant recipient
                                        under this subparagraph'' and
                                        inserting ``subsequent renewal
                                        grant to a grant recipient
                                        under subparagraph (E)''; and
                                            (cc) by striking ``initial
                                        additional grant'' and
                                        inserting ``renewal grant under
                                        subparagraph (E)''; and
                    (B) in paragraph (4), by striking ``(3)(E)'' and
                inserting ``(3)(G)'';
            (2) in subsection (d)--
                    (A) by striking ``In awarding'' and inserting the
                following:
            ``(1) Priority for economically disadvantaged areas.--In
        awarding''; and
                    (B) by adding at the end the following:
            ``(2) Priority for states demonstrating high mortality
        rates relating to opioid use disorder.--
                    ``(A) Grants to more than 1 eligible coalition
                representing a community.--In awarding grants under
                subsection (b)(1)(B)(ii), the Administrator shall give
                priority to eligible coalitions that serve 1 or more
                communities in a State that has a high mortality rate
                relating to opioid use disorder.
                    ``(B) Subsequent additional grants.--In awarding
                subsequent additional grants under subsection
                (b)(3)(D), the Administrator shall give priority to an
                eligible coalition that serves 1 or more communities in
                a State that has a high mortality rate relating to
                opioid use disorder.''; and
            (3) by adding at the end the following:
    ``(e) Limitation on Subsequent Renewal Grants.--A recipient of a
subsequent renewal grant awarded under subsection (b)(3)(F) may not be
awarded any further grant under this section.''.

SEC. 13. SUPPORT FOR LAW ENFORCEMENT MENTAL HEALTH AND WELLNESS.

    There is authorized to be appropriated, and there is appropriated,
out of any monies in the Treasury not otherwise appropriated,
$15,000,000 for each of fiscal years 2027 through 2030 for grants under
section 1701(b)(25) of title I of the Omnibus Crime Control and Safe
Streets Act of 1968 (34 U.S.C. 10381(b)(25)) to establish peer
mentoring mental health and wellness pilot programs within State,
Tribal, and local law enforcement agencies.

SEC. 14. ADVERSE CHILDHOOD EXPERIENCES RESPONSE TEAM GRANT PROGRAM.

    (a) In General.--Title I of the Omnibus Crime Control and Safe
Streets Act of 1968 (34 U.S.C. 10101 et seq.) is amended by adding at
the end the following:

  ``PART PP--ADVERSE CHILDHOOD EXPERIENCES RESPONSE TEAM GRANT PROGRAM

``SEC. 3061. GRANTS FOR ADVERSE CHILDHOOD EXPERIENCES RESPONSE TEAMS.

    ``(a) Grants Authorized.--From amounts made available to carry out
this section, the Attorney General, in coordination with the Secretary
of Health and Human Services, shall make grants to States, units of
local government, Indian Tribes, and neighborhood or community-based
organizations to address adverse childhood experiences associated with
exposure to trauma.
    ``(b) Use of Funds.--Amounts received under a grant under this
section may be used to establish an adverse childhood experiences
response team, including by--
            ``(1) establishing protocols to follow when encountering a
        child or youth exposed to trauma to facilitate access to
        services;
            ``(2) developing referral partnership agreements with
        behavioral health providers, substance treatment facilities,
        and recovery services for family members of children exposed to
        trauma;
            ``(3) integrating law enforcement, mental health, and
        crisis services to respond to situations where children have
        been exposed to trauma;
            ``(4) implementing comprehensive programs and practices to
        support children exposed to trauma;
            ``(5) identifying barriers for children to access trauma-
        informed care in their communities;
            ``(6) providing training in trauma-informed care to
        emergency response providers, victim service providers, child
        protective service professionals, educational institutions, and
        other community partners;
            ``(7) supporting cross-system planning and collaboration
        among officers and employees who work in law enforcement, court
        systems, child welfare services, correctional reentry programs,
        emergency medical services, health care services, public
        health, and substance abuse treatment and recovery support; and
            ``(8) providing technical assistance to communities,
        organizations, and public agencies on how to prevent and
        mitigate the impact of exposure to trauma and violence.
    ``(c) Application.--A State, unit of local government, Indian
Tribe, or neighborhood or community-based organization desiring a grant
under this section shall submit to the Attorney General an application
in such form, and containing such information, as the Attorney General
may reasonably require.''.
    (b) Authorization of Appropriations.--Section 1001(a) of title I of
the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C.
10261(a)) is amended by adding at the end the following:
    ``(29) There are authorized to be appropriated to carry out part PP
$10,000,000 for each of fiscal years 2027 through 2030.''.
                                 <all>